Akebia Therapeutics Inc. buy BTIG Research
Start price
07.04.26
/
50%
€1.18
Target price
07.04.27
€3.47
Performance (%)
-32.79%
Price
09:32
?
Summary
This prediction is currently active. Massive losses of -32.79% have been the result for the BUY prediction by BTIG_Research. This prediction currently runs until 07.04.27. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Akebia Therapeutics Inc. | -7.102% | -7.102% |
| iShares Core DAX® | -1.862% | -1.624% |
| iShares Nasdaq 100 | -3.322% | 3.321% |
| iShares Nikkei 225® | -2.299% | 3.437% |
| iShares S&P 500 | -1.313% | 2.435% |
Comments by BTIG_Research for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics (AKBA) had its "buy" rating reaffirmed by BTIG Research. They now have a $4.00 price target on the stock.
Ratings data for AKBA provided by MarketBeat
Stopped prediction by BTIG_Research for Akebia Therapeutics Inc.
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.08
25.02.26
25.02.26
€3.39
25.02.27
25.02.27
-25.11%
09:32
09:32
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.27
02.12.25
02.12.25
€4.31
02.12.26
02.12.26
-36.75%
09:32
09:32
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.93
29.10.25
29.10.25
€4.29
29.10.26
29.10.26
-58.21%
09:32
09:32
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.92
29.11.23
29.11.23
€3.64
29.11.24
29.11.24
122.78%
30.11.24
30.11.24